threonine and Epithelial Neoplasms

threonine has been researched along with Epithelial Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dziadek, S; Kunz, H	1
André, S; Detjen, KM; Fischer, C; Gabius, HJ; Khachigian, L; Rosewicz, S; Sakai, T; Sanchez-Ruderisch, H; Welzel, M; Wiedenmann, B	1

Other Studies

2 other study(ies) available for threonine and Epithelial Neoplasms

Article	Year
Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines. Chemical record (New York, N.Y.), 2004, Volume: 3, Issue:6 Topics: Antigens, Tumor-Associated, Carbohydrate; Asialoglycoproteins; Cancer Vaccines; Glycopeptides; Humans; Immunization; Mucins; Neoplasms, Glandular and Epithelial; Oligosaccharides; Sialic Acids; Threonine	2004
Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. The Journal of biological chemistry, 2005, Nov-04, Volume: 280, Issue:44 Topics: Adenocarcinoma; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase; Galectin 1; Genes, ras; Humans; Integrin alpha5beta1; MAP Kinase Kinase Kinases; Neoplasms, Glandular and Epithelial; Phosphorylation; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Threonine; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured	2005

Article

Year

Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.

Chemical record (New York, N.Y.), 2004, Volume: 3, Issue:6

Topics: Antigens, Tumor-Associated, Carbohydrate; Asialoglycoproteins; Cancer Vaccines; Glycopeptides; Humans; Immunization; Mucins; Neoplasms, Glandular and Epithelial; Oligosaccharides; Sialic Acids; Threonine

2004

Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27.

The Journal of biological chemistry, 2005, Nov-04, Volume: 280, Issue:44

Topics: Adenocarcinoma; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase; Galectin 1; Genes, ras; Humans; Integrin alpha5beta1; MAP Kinase Kinase Kinases; Neoplasms, Glandular and Epithelial; Phosphorylation; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Threonine; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured

2005